Clover Biopharmaceuticals



Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases.

David He
Joshua Liang
Chief Strategy Officer & Board Director
Min Dong
EVP, Global Clinical Development
Steven Gong
VP, Strategy & BD
Zheng Ping
Director, Operations & Board Director
Phillip Lee
Chief Financial Officer & Chief Business Officer
Philippe Bishop
Chief Medical Officer, Oncology
Htay Htay Han
Chief Medical Officer, Vaccines
Xiaobing Li
EVP, Product Development & Portfolio Management
Brian Krex
General Counsel
Mike Berry
Chief Technical Operations Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.